Sec. 15. Annual audits by GAO
129 words·~1 min read·
/bill/115/s/495/is/section-15·A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
The Comptroller General of the United States shall conduct an audit of the Board every fifth fiscal year following the date of enactment of this Act to determine the effectiveness of the Board— in bringing to market drugs, vaccines and other biological products, and new manufacturing processes for medicines in a cost-effective manner; and in addressing society's medical needs, including global neglected diseases that afflict primarily the poor in developing countries, indications for which orphan designation has been granted under section 526 of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 360bb ), and global infectious diseases and other global public health priorities.
The Comptroller General of the United States shall submit a report to the Congress concerning the results of each audit conducted under subsection (a).
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 15
Annual audits by GAO
Cites 1Cited by 0 across 0 sources